The Firm is representing Apria, Inc. (Nasdaq: APR) (“Apria”), in connection with Apria’s proposed acquisition by Owens & Minor, Inc. (NYSE: OMI) (“Owens & Minor”), for $37.50 in cash per share, representing an equity value of approximately $1.45 billion, as well as the assumption of debt and cash for a total transaction value of approximately $1.6 billion. The transaction is subject to customary closing conditions, including the approval of Apria’s stockholders, and is expected to close during the first half of 2022.
Apria is a provider of integrated home healthcare equipment and related services in the United States. Owens & Minor is a global healthcare solutions company that incorporates product manufacturing, distribution support and innovative technology services to deliver significant and sustained value across the breadth of the industry – from acute care to patients in their home.
The Simpson Thacher team includes Anthony Vernace, Michael Chao, Austin Uhm, Beini Chen and Kevin Perron (M&A); Jeannine McSweeney (Executive Compensation and Employee Benefits); Peter Guryan and Max Fischer-Zernin (Antitrust); Daniel Kay and Catherine Burns (Credit); Edgar Lewandowski (Capital Markets); Jonathan Goldstein and Ruoxi Zhang (Tax); Lori Lesser (Intellectual Property); Vanessa Burrows (Healthcare); Krista McManus, Dennis Loiacono and Stephanie Brenner (Real Estate); and Charles Mathes (Public Company Advisory).